Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit Hyperactivity Disorder (ADHD)

Explore clinical trials studying Attention Deficit Hyperactivity Disorder (ADHD). Study availability and eligibility vary by location and protocol.

77 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit Hyperactivity Disorder (ADHD) trial results

Completed

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)

NCT02618434

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Metropolitan Neuro Behavioral Institute Chandler, Arizona, United States
  • Woodland International Research Group Little Rock, Arkansas, United States
  • Sun Valley Research Center Imperial, California, United States
  • Alliance for Wellness dba Alliance for Research Long Beach, California, United States
View all 32 locations
View Trial Details
Completed

Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)

NCT02618408

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Woodland Research Northwest Rogers, Arkansas, United States
  • ProScience Culver City, California, United States
  • Behavioral Research Specialists Glendale, California, United States
  • Neuropsychiatric Research Center of Orange County Orange, California, United States
View all 28 locations
View Trial Details
Completed

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

NCT00500071

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Melmed Center Scottsdale, Arizona, United States
  • Valley Clinical Research El Centro, California, United States
  • Peninsula Research Assoc, Inc Rolling Hills Estates, California, United States
  • UCSF-Langely Porter Psych Institute San Francisco, California, United States
View all 46 locations
View Trial Details
Completed

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

NCT01500694

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Medizinische Universitat Graz Univ fur Kinder Graz, Austria
  • Institut fur Psychosomatik Vienna, Austria
  • Universitaire Kinder-end Jeugdpsychatrie Hoboken, Belgium
  • Centre de Reference Neuropediatrique Multidisciplinaire Namur, Belgium
View all 60 locations
View Trial Details
Completed

Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00735371

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • Clinical Study Centers, LLC Little Rock, Arkansas, United States
  • Valley Clinical Research, Inc. El Centro, California, United States
  • Peninsula Research Associates, Inc Rolling Hills Estates, California, United States
  • Psychiatric Centers at San Diego (PCSD-Feighner Research Institute) San Diego, California, United States
View all 45 locations
View Trial Details
Completed

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT01328756

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • ZNA Antwerpen, Commandant Weynsstraat 165 Campus Hoge Beuken Hoboken, Antwerp, Belgium
  • Afdeling Psychiatrie Leuven, Belgium
  • Albert-Ludwigs-Universität Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Zentralinstitut für Seelische Gesundheit Mannheim Mannheim, Baden-Wurttemberg, Germany
View all 35 locations
View Trial Details

Related conditions